Roivant Sciences Officer Files Form 144 Notice of Proposed Sale
Roivant Sciences Ltd.
Subscribe to track ROIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 Form 144 Notice of Proposed Sale
Company: Roivant Sciences Ltd. (ROIV) Insider: Meghan Fitzgerald (Officer) Proposed Sale Shares: 5,112 Common Shares Aggregate Market Value: $209,694.24 Approximate Sale Date: 09/15/2026 Broker: Morgan Stanley Smith Barney LLC Plan Adoption Date: 03/30/2026 (10b5-1 Plan)
Comprehensive Analysis
Executive Summary
On September 15, 2026, Roivant Sciences Ltd. officer Meghan Fitzgerald filed a Form 144 notice indicating the proposed sale of 5,112 common shares with an estimated aggregate market value of $209,694.24. The sale is scheduled to occur through Morgan Stanley Smith Barney LLC.
Transaction & Acquisition Details
- Securities to be Sold: 5,112 Common Shares
- Nature of Acquisition: Restricted Stock Units acquired from the issuer on September 10, 2026.
- Approximate Sale Date: September 15, 2026
- Trading Plan: Adopted under Rule 10b5-1 on March 30, 2026.
Recent 3-Month Sales History
- September 8, 2026: 20,000 Common Shares sold for $798,010.00 under Rule 10b5-1.
- June 30, 2026: 10,000 Common Shares sold for $349,000.00 under Rule 10b5-1.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.